Sterilizable, weldable, sealable thermoplastic elastomer tubing intended for biopharmaceutical processing applications that require low temperatures

DuPont  announced it has launched DuPont^™ Liveo^™ Pharma TPE Ultra-Low Temp Tubing, a new thermoplastic elastomer tubing designed to withstand the low temperatures required for many of today's biopharmaceutical processing applications.

Sterilizable, weldable, sealable Liveo^™ Pharma TPE Ultra-Low Temp Tubing is an ISO Class 7 cleanroom-manufactured tubing that offers improved elastomer toughness and ductility down to -86 °C; resistance to bend, crush and impact at -80 °C; good pumpability and low spallation; and excellent burst pressure resistance and chemical resistance. The phthalate-free tubing's purity and regulatory data include USP Class VI standards, extractables USP <665>, elemental impurities USP <232> and Biocompatibility ISO 10993 (part 5, 6, 11, 23), among others. A comprehensive data package is available to facilitate qualification and validation.

"In recent years, there's been increasing demand for high-purity materials that can meet the biopharmaceutical processing industry's needs for low-temperature exposure," said Diana Salvadori, DuPont Global Senior Product Marketing Manager for Biopharma Processing. "With our new Liveo™ Pharma TPE Ultra-Low Temp Tubing, DuPont is offering an additional thermoplastic elastomer tubing option for fluid transport and single-use bioprocessing applications, facilitating adoption and compatibility with alternative TPE tubing offerings."

Liveo™ Pharma TPE Ultra-Low Temp Tubing is the second TPE tubing product launched by DuPont in recent years, joining Liveo™ Pharma TPE Tubing in the company's portfolio of solutions for biopharma processing applications – which also includes numerous silicone-based tubing and overmolded assembly (OMA) products.

"DuPont's TPE tubing products complement our silicone-based Liveo™ Pharma range – and they are produced under the same high-quality principles as our products that already are known and trusted by the biopharma industry," Salvadori said.